Navigation Links
Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering
Date:11/18/2009

sedran@canaccordadams.com

Before you invest, you should read the prospectus supplement and accompanying prospectus, the registration statement, and the other documents that the Company has filed with the United States Securities and Exchange Commission for more complete information about the Company and this offering.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration of qualification under the securities laws of any state or jurisdiction.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to timing and closing of the placement of units, common stock and warrants; the Company's belief as to the potential of REOLYSIN as a cancer therapeutic; the Company's expectations as to the success of its research and development programs in 2009 and beyond, the Company's planned operations, the value of the additional patents and intellectual property; the Company's expectations related to the applications of the patented technology; the Company's expectations as to adequacy of its existing capital resources; the design, timing, success of planned clinical trial programs; and other statements related to anticipated developments in the Company's business and technologies involve
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Oncolytics Biotech Inc. announces approval for UK clinical trial
2. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
3. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
4. AMA Optics Announces New Brightness Acuity Meter -- Documents Disabling Glare from Cataract
5. Tyco International Announces Exchange Rate for Quarterly Dividend
6. Shopko Announces Launch of e-Commerce Platform
7. Driven by Customer Feedback, BodyMedia, Inc. Announces Major Enhancements and Brand Change for GoWear Fit
8. Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting
9. United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results
10. MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition
11. US Farms, Inc. Announces Completion of Construction for New 3000 Square Foot Greenhouse Shipping and Packing Facility for Nursery Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... PROVIDENCE, R.I. (PRWEB) May 04, 2015 Johnson ... new $40 million engineering and science academic center on Wednesday, ... in the ground for land made available by the re-alignment ... at the corner of Friendship and Chestnut streets in Providence, ... being built on a parcel of land the university purchased ...
(Date:5/4/2015)... Ana, CA (PRWEB) May 04, 2015 The ... live a full life are the motivating forces behind The ... California clinical psychologist and author Amy L. Stark. , The ... the little girl next door comes from Stark’s desire to ... Stark. “I’ve been a fairy godmother to my neighbors’ children ...
(Date:5/4/2015)... 04, 2015 Now in its seventh ... leaders who have made outstanding contributions to the company, ... both in acute and post-acute care settings. The five ... Provider of the Year, Advanced Practice Clinician of the ... of the Year. Recipients are selected by IPC’s senior ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the most ... this beloved performer continues to roll along with no signs ... legendary groups: Wings and The Beatles, has been celebrating his ... the “Out There” tour and has continually added new stops ...
(Date:5/4/2015)... Diego, CA (PRWEB) May 04, 2015 ... a ribbon cutting ceremony at their brand new, 13,700 ... this year. The new building will not only provide ... population, but will also offer community and educational events ... The new facility is located next door to their ...
Breaking Medicine News(10 mins):Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... , CHICAGO and RALEIGH, N.C., Aug. ... focused exclusively on the awareness, testing and conversation of ... transmitted infection (STI) education and advocacy organization is now ... , , Since 1914, the ...
... , , SANTA MONICA, Calif., ... Kent Conrad (D-ND) and a number of Senate conservatives have been ... they would not have the market clout to leverage discounts and ... a path to gutting state consumer protection laws, according to the ...
... Decline seen as sign of progress against drug-resistant ... Prescribing antibiotics to treat respiratory tract infections has ... has found. , That,s mainly the result of ... according to the researchers. But despite a decline ...
... Gardasil, study finds, , TUESDAY, Aug. 18 (HealthDay News) ... a cause of cervical cancer, appears safe, with relatively ... government study. , The study, which included data ... found that the rate of serious adverse events for ...
... ... automating claims processing with Corticon Business Rules Platform , ... Redwood City, CA (PRWEB) August 18, 2009 -- Corticon Technologies ... project: American Community Mutual Insurance Company® (ACMIC) has gone live with an ...
... , , , ... and Aging has released "Technologies To Help Older Adults Maintain ... technology areas with significant potential of improving chronic health care ... care costs. , , "Spending on ...
Cached Medicine News:Health News:Confidential Online STD Testing Clinic, GetSTDTested.com, Strengthens Partnership With ASHA in the Fight Against STDs 2Health News:Confidential Online STD Testing Clinic, GetSTDTested.com, Strengthens Partnership With ASHA in the Fight Against STDs 3Health News:Sen. Conrad's Health Insurance Co-Ops Won't Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog 2Health News:Sen. Conrad's Health Insurance Co-Ops Won't Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog 3Health News:Sen. Conrad's Health Insurance Co-Ops Won't Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog 4Health News:Antibiotics Being Prescribed Less for Respiratory Infections 2Health News:Antibiotics Being Prescribed Less for Respiratory Infections 3Health News:Cervical Cancer Vaccine Seems Safe 2Health News:Cervical Cancer Vaccine Seems Safe 3Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 2Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 3Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 4Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 2Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 3
(Date:5/4/2015)... ANGELES , May 4, 2015  CytRx ... and development company specializing in oncology, today announced ... 1b aldoxorubicin combination studies pairing aldoxorubicin with either ... of gemcitabine or ifosfamide with escalating doses of ... and even at the lowest dose level of ...
(Date:5/4/2015)... 2015 Unchained Labs, a refreshingly new biologic ... PEGS conference and launches the UNit — the first ... The Essential Protein Engineering Summit takes place in ... The UNit lets drug discovery researchers look at more ... Its 7 applications, 144 sample a day throughput and ...
(Date:5/4/2015)... 4, 2015  Geneia, a company of experienced ... to improve healthcare efficiencies, today announced a first-of-its-kind ... (BNRC) use Geneia,s advanced analytics solution coupled ... quality and lower the cost of patient care. ... claims and utilization data from multiple sources to ...
Breaking Medicine Technology:CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7Unchained Labs Lets the UNit Loose 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3
... 24, 2011 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... discovering breakthrough treatments for human disease, announced today that ... chief medical officer, responsible for directing clinical development of ... 3 and approval.  Dr. Lapuerta has 15 years of ...
... Texas, March 24, 2011 St. David,s HealthCare today ... at St. David,s North Austin Medical Center, which will ... epicenter teaching best practices for hospital and surgical teams ... Institute for Robotic Surgery at St. David,s North Austin ...
Cached Medicine Technology:Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer 2Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer 3St. David's HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. David's North Austin Medical Center 2St. David's HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. David's North Austin Medical Center 3St. David's HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. David's North Austin Medical Center 4St. David's HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. David's North Austin Medical Center 5
... Mosaic, the third generation tissue valve ... stented tissue valve available. The Mosaic valve ... experience and is an excellent choice for ... replacement with a tissue valve. For more ...
Medtronic Aortic Punches are intended for use by cardiac surgeons during coronary artery bypass grafting procedures to create an opening in the wall of the vessel. All punches are sterile and disposa...
... Implantable defibrillators are used to treat ... life threatening. Implantable cardioverter defibrillators (ICDs) often ... (SCD), and have been found to reduce ... from as high as 55 percent to ...
... High Frequency Ultrasound system is the most ... system available. The HF35-50 allows users to ... anterior segment with 35MHz or 50MHz probes ... a 20 MHz sealed B-probe. , ,The ...
Medicine Products: